| Jun'19 | Jun'18 | Jun'17 | Jun'16 | Jun'15 | Jun'14 | |
|---|---|---|---|---|---|---|
Revenues | ||||||
1,914 | 1,798 | 1,730 | 2,114 | 2,063 | 1,976 | |
Expenses: | ||||||
Cost of revenues | ||||||
899 | 854 | 898 | 1,243 | 1,273 | 1,204 | |
Selling, general and administrative expenses | ||||||
444 | 441 | 433 | 448 | 431 | 411 | |
Restructuring expenses | ||||||
28 | 20 | 17 | 20 | 2 | 0 | |
Litigation provision | ||||||
90 | 0 | 0 | - | - | - | |
Separation costs | ||||||
- | - | - | - | 34 | 9 | |
Total expenses | ||||||
1,462 | 1,316 | 1,349 | 1,712 | 1,741 | 1,625 | |
Operating earnings | ||||||
452 | 481 | 381 | 402 | 322 | 350 | |
Interest expense | ||||||
139 | 95 | 57 | 40 | 28 | 1 | |
Income (Loss) from Equity Method Investments | ||||||
-17 | 0 | 0 | - | - | - | |
Other income (loss), net | ||||||
7 | 13 | 3 | 6 | 6 | 3 | |
Earnings before income taxes | ||||||
303 | 399 | 327 | 369 | 299 | 353 | |
Provision for income taxes | ||||||
62 | 88 | 92 | 122 | 113 | 117 | |
Net earnings from continuing operations | ||||||
241 | 311 | 234 | - | - | - | |
Net earnings (loss) from discontinued operations | ||||||
-109 | 77 | 67 | - | - | - | |
Net earnings | ||||||
131 | 388 | 302 | 246 | 186 | 235 | |
Less: net earnings attributable to noncontrolling interest | ||||||
7 | 7 | 6 | 7 | 7 | 8 | |
Net earnings attributable to CDK | ||||||
124 | 380 | 295 | 239 | 178 | 227 | |
Net earnings (loss) attributable to CDK per share - basic: | ||||||
Continuing operations (in dollars per share) | ||||||
1.86 | 2.23 | 1.55 | - | - | - | |
Discontinued operations (in dollars per share) | ||||||
-0.87 | 0.57 | 0.46 | - | - | - | |
Total net earnings attributable to CDK per share - basic (in dollars per share) | ||||||
0.99 | 2.80 | 2.01 | 1.52 | 1.11 | 1.42 | |
Net earnings (loss) attributable to CDK per share - diluted: | ||||||
Continuing operations (in dollars per share) | ||||||
1.85 | 2.21 | 1.53 | - | - | - | |
Discontinued operations (in dollars per share) | ||||||
-0.87 | 0.57 | 0.46 | - | - | - | |
Total net earnings attributable to CDK per share - diluted (in dollars per share) | ||||||
0.98 | 2.78 | 1.99 | 1.51 | 1.10 | 1.42 | |
Weighted-average common shares outstanding: | ||||||
Basic (shares) | ||||||
125 | 135 | 146 | 157 | 160 | 160 | |
Diluted (shares) | ||||||
126 | 136 | 148 | 158 | 161 | 160 | |